Trial intelligence / Profile preview

MAGNET trial of nebulised magnesium sulphate in moderate/severe acute childhood asthma

2004-003825-29Phase 2Unknown

Sponsor
Cardiff and Vale University Health Board
Start
May 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in asthma comparing Nebulised magnesium sulphate with Placebo isotonic saline (2 arms). Primary endpoints: Mean slope of improvement of Asthma Severity Score, Additional salbutamol use and 3 more. Status: unknown.

02

Drugs

magnesium sulfate
03

Conditions

asthma

Beyond the preview

Go deeper on 2004-003825-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-003825-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call